ARTICLE | Company News
Bioventix Ltd., Xenova deal
January 12, 2004 8:00 AM UTC
In line with its declared strategy, XEN sold to Bioventix certain assets obtained through its acquisition of KS Biomedix for £800,000 ($1.4 million) (see BioCentury, Aug. 18, 2003). The sale includes ...